Clinical Trials on Hemostatics
Total 4391 results
-
Hoffmann-La RocheRecruitingMultiple MyelomaKorea, Republic of, Australia, Spain, France, Poland
-
GPCR Therapeutics, Inc.Recruiting
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Xuzhou Medical UniversityRecruiting
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaKorea, Republic of, Russian Federation, Spain, Germany, Belgium, Denmark, Greece, France, United States, Ukraine, Poland
-
Xia ZhongjunAntengene CorporationRecruiting
-
Memorial Sloan Kettering Cancer CenterRecruiting
-
Fondazione EMN Italy OnlusRecruiting
-
Bristol-Myers SquibbRecruitingMultiple MyelomaNorway, United States, Spain, United Kingdom, Canada
-
Bioray LaboratoriesThe First Affiliated Hospital of Zhengzhou UniversityNot yet recruiting
-
Canadian Myeloma Research GroupNot yet recruiting
-
Stichting European Myeloma NetworkJanssen Research & Development, LLCRecruitingMultiple MyelomaNetherlands, United States, Spain, Belgium, France, Italy, Germany, Japan, Canada, Australia, Sweden, Israel, United Kingdom, Czechia, Greece, Switzerland, Norway
-
Stichting European Myeloma NetworkJanssen PharmaceuticaRecruitingMultiple MyelomaUnited Kingdom, Czechia, Australia, Austria, Belgium, Denmark, Germany, Greece, Italy, Netherlands, Norway, Serbia, Switzerland, Turkey, Brazil
-
University of Alabama at BirminghamJanssen Scientific Affairs, LLCRecruitingMultiple MyelomaUnited States
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Belgium, China, Israel, Netherlands, Spain, Japan
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaUnited States, Spain, France, Greece
-
European Myeloma NetworkKaryopharm Therapeutics IncRecruitingMultiple MyelomaSpain, United States, Germany, Netherlands, Greece, France, Italy
-
CelgeneRecruitingMultiple MyelomaAustria, Italy, China, Australia, Spain, United States, Korea, Republic of, Taiwan, Germany, Ireland, Argentina, Brazil, Mexico, Netherlands, Belgium, Czechia, France, Greece, Japan, Poland, Israel, United Kingdom, Norway, Denmark, Finland and more
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Korea, Republic of, Denmark, Czechia, Israel, Switzerland, Belgium, United Kingdom, Japan, Argentina, Sweden, Canada, Spain, Germany, Netherlands, France, Brazil, Greece, Poland, Ireland, Hungary, Portugal, Australia, F... and more
-
Fuling ZhouRecruiting
-
Medical College of WisconsinRecruitingMultiple MyelomaUnited States
-
University of RochesterRecruitingMultiple MyelomaUnited States
-
Xinqiao Hospital of ChongqingCarbiogene Therapeutics Co. Ltd.Recruiting
-
Janssen Research & Development, LLCRecruitingMultiple MyelomaUnited States, Korea, Republic of, Canada, Israel, Spain, Japan, Australia
-
GlaxoSmithKlineRecruitingMultiple MyelomaChina, Korea, Republic of, Australia, Italy, Spain, United States, Brazil, Czechia, France, Germany, Greece, Israel, Japan, New Zealand, Poland, Russian Federation, Turkey, United Kingdom
-
GlaxoSmithKlineRecruitingMultiple MyelomaAustralia, Germany, Italy, Spain, United States, Korea, Republic of, Canada, France, Poland, United Kingdom
-
University Hospital, EssenRecruitingHereditary Haemorrhagic TelangiectasiaGermany
-
University of Turin, ItalyRecruiting
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaBelgium, United States, Japan, Korea, Republic of, Germany, Spain, United Kingdom
-
University of ChicagoRecruiting
-
University Hospital, ToulouseRecruiting
-
Swedish Medical CenterRecruiting
-
CelgeneRecruitingMultiple MyelomaKorea, Republic of
-
Scientific Institute San RaffaeleUniversità Vita-Salute San RaffaeleRecruitingThrombosis | Blood Coagulation Disorder | Platelet Thrombus | Platelet Dysfunction Due to Aspirin | Failure;VentricularItaly
-
OncotherapeuticsIncyte CorporationRecruitingMultiple MyelomaUnited States
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, Bulgaria, Poland, Belgium, France, Germany, Italy, Hungary, United Kingdom, Greece, Russian Federation, Brazil, China, Korea, Republic of, Japan, Canada, Netherlands
-
National Cancer Institute (NCI)Active, not recruitingMultiple MyelomaUnited States, Israel
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Germany, Italy, Spain, Sweden, Japan
-
Janssen Research & Development, LLCActive, not recruitingMultiple MyelomaUnited States, France, United Kingdom, Belgium, Germany, Israel, Australia, Sweden, Canada, Netherlands, Austria, Ireland, Denmark
-
Gilead SciencesCompletedMultiple MyelomaUnited States, Czechia, Canada
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States
-
Amsterdam UMC, location VUmcCelgeneActive, not recruitingMultiple MyelomaNetherlands
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Italy, Czechia, Denmark, France, Germany, Greece, Spain
-
PfizerIn Expanded Access, treating physicians are the SponsorsAvailable
-
PfizerActive, not recruitingMultiple MyelomaUnited States, Canada, Spain, Belgium, United Kingdom, Australia, Japan, France, Germany, Poland
-
GlaxoSmithKlineCompleted
-
Massachusetts General HospitalMultiple Myeloma Research ConsortiumActive, not recruitingMultiple MyelomaUnited States
-
Constellation PharmaceuticalsThe Leukemia and Lymphoma SocietyCompleted
-
Bristol-Myers SquibbAbbVieActive, not recruitingMultiple MyelomaUnited States, Canada, Australia, Poland, Italy, Belgium, Spain, Japan, Greece, Hungary, Romania, Turkey, United Kingdom